Amanote Research
Register
Sign In
642. Pre-Existing Antiviral State Can Impact Oncolytic Infection in Glioblastoma Patients Treated With Oncolytic Measles Virus
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35655-6
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2014
Authors
Unknown
Publisher
Elsevier BV
Related search
Specific Elimination of CD133+ Tumor Cells With Targeted Oncolytic Measles Virus
Cancer Research
Cancer Research
Oncology
Oncolytic Measles Virus Therapy Enhances Tumor Antigen-Specific T-Cell Responses in Patients With Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
639. MicroRNA-Mediated Multi-Tissue-Detargeting of Oncolytic Measles Virus
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Correction: Zika Virus Has Oncolytic Activity Against Glioblastoma Stem Cells
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Characterizing Cellular Responses During Oncolytic Maraba Virus Infection
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Oncolytic Myxoma Virus Synergizes With Standard of Care for Treatment of Glioblastoma Multiforme
Oncolytic Virotherapy
Potential and Clinical Translation of Oncolytic Measles Viruses
Expert Opinion on Biological Therapy
Drug Discovery
Clinical Biochemistry
Pharmacology
Analysis of Predictive and Prognostic Factors in 290 Patients Treated With Oncolytic Adenoviruses
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus
Cancer Research
Cancer Research
Oncology
